These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8985979)

  • 1. Purification of transforming growth factor beta 1 from human platelets.
    Werz O; Brungs M; Steinhilber D
    Pharmazie; 1996 Nov; 51(11):893-6. PubMed ID: 8985979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine transforming growth factor beta. Purification and characterization.
    Popik W; Inglot O
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):715-24. PubMed ID: 2487381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for high yield purification of type beta transforming growth factor from human platelets.
    van den Eijnden-van Raaij AJ; Koornneef I; van Zoelen EJ
    Biochem Biophys Res Commun; 1988 Nov; 157(1):16-23. PubMed ID: 3196328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human transforming growth factor-beta 1: expression by Chinese hamster ovary cells, isolation, and characterization.
    Bourdrel L; Lin CH; Lauren SL; Elmore RH; Sugarman BJ; Hu S; Westcott KR
    Protein Expr Purif; 1993 Apr; 4(2):130-40. PubMed ID: 8471846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent forms of transforming growth factor-beta (TGF beta) derived from bone cultures: identification of a naturally occurring 100-kDa complex with similarity to recombinant latent TGF beta.
    Bonewald LF; Wakefield L; Oreffo RO; Escobedo A; Twardzik DR; Mundy GR
    Mol Endocrinol; 1991 Jun; 5(6):741-51. PubMed ID: 1922093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.
    van Waarde MA; van Assen AJ; Kampinga HH; Konings AW; Vujaskovic Z
    Anal Biochem; 1997 Apr; 247(1):45-51. PubMed ID: 9126369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of platelet-derived endothelial cell growth inhibitor and its characterization as transforming growth factor-beta type 1.
    Magyar-Lehmann S; Böhlen P
    Experientia; 1992 Apr; 48(4):374-9. PubMed ID: 1316287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta and a mesoderm inducing factor from human blood platelets are different proteins.
    Dau H; Wedlich D; Born J; Loppnow-Blinde B; Tiedemann H; Tiedemann H
    FEBS Lett; 1990 Oct; 273(1-2):68-70. PubMed ID: 2226866
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimization of platelet isolation and extraction of autogenous TGF-beta in cartilage tissue engineering.
    Staudenmaier R; Froelich K; Birner M; Kindermann J; The Hoang N; Pueschel RC; Mandlik V
    Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(6):265-72. PubMed ID: 19922166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-beta.
    Celotti F; Colciago A; Negri-Cesi P; Pravettoni A; Zaninetti R; Sacchi MC
    Wound Repair Regen; 2006; 14(2):195-202. PubMed ID: 16630109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential growth factor retention by platelet-rich plasma composites.
    Tsay RC; Vo J; Burke A; Eisig SB; Lu HH; Landesberg R
    J Oral Maxillofac Surg; 2005 Apr; 63(4):521-8. PubMed ID: 15789325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
    Pihusch V; Pihusch M; Penovici M; Kolb HJ; Hiller E; Pihusch R
    Thromb Res; 2005; 116(3):233-40. PubMed ID: 15935832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent TGF-beta1 activation by platelets.
    Blakytny R; Ludlow A; Martin GE; Ireland G; Lund LR; Ferguson MW; Brunner G
    J Cell Physiol; 2004 Apr; 199(1):67-76. PubMed ID: 14978736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of co-measured platelet factor 4 in the reliability of the results of the plasma transforming growth factor-beta 1 measurement.
    Jeon JH; Kim YS; Choi EJ; Cheon S; Kim S; Kim JS; Jang JS; Ha WS; Park ST; Park CS; Park K; Park BK
    Cytokine; 2001 Nov; 16(3):102-5. PubMed ID: 11741350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Western blotting of transforming growth factor beta 2. Optimization of the electrophoretic transfer.
    Jin Y; Cerletti N
    Appl Theor Electrophor; 1992; 3(2):85-90. PubMed ID: 1477118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.
    Zou Z; Sun PD
    Protein Expr Purif; 2004 Oct; 37(2):265-72. PubMed ID: 15358346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts.
    Petrov VV; Fagard RH; Lijnen PJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):342-52. PubMed ID: 11967821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
    Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
    Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation.
    Folger PA; Zekaria D; Grotendorst G; Masur SK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2534-41. PubMed ID: 11581194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
    Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.